Throboxane Effect on Chondrocytes; Role in Osteoarthritis
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- to look for correlation between the rate of throboxane and the grade of osteoarthritis
研究概览
简要总结
TXA2 inhibits the expression of the primary marker of thermogenesis (UCP1) while prostacyclin (PGI2), another metabolite derived from arachidonic acid, enhances its expression. Given the close relationship between the adipocyte and the chondrocyte, the study team hypothesises that thromboxane A2 controls chondrocyte formation and function and thus cartilage homeostasis. The study objectives are: i) to analyse the role of TXA2 on chondrocyte differentiation in vitro, ii) to determine the association between circulating and tissue TXA2 levels in a rat model of osteoarthritis, and iii) to correlate circulating and synovial fluid levels of TXA2 with the development of osteoarthritis in a small human cohort. The proposed research aims to better understand the mechanisms underlying the role of lipid metabolites in chondrocyte formation and function, paving the way for the development of nutritional and pharmacological therapies to combat OA and associated metabolic disorders.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •presence of knee osteoarthritis with effusion, , no inflammatory disease
排除标准
- •anticoagulant treatment
- •inflammatory disease
研究组 & 干预措施
ThroboxaneOA
Patient with osteoarthritis and knee effusion
干预措施: biological samples (Other)
结局指标
主要结局
to look for correlation between the rate of throboxane and the grade of osteoarthritis
时间窗: 6 months
kellgren and lawrence classification
次要结局
未报告次要终点
